LETTER TO EDITOR
Year : 2020 | Volume
: 3 | Issue : 2 | Page : 325--326
Maintaining a sense of optimism-Carl Rogers
Tejaswini Mohan, Kavya Nambiar
Department of Medical Oncology, Tata Memorial Hospital, Homi Bhabha National Institute, Mumbai, Maharashtra, India
I-2301, Ravi Estate, Pokhran Road 1 and 2 Link Road, Thane West - 400 606, Maharashtra
|How to cite this article:|
Mohan T, Nambiar K. Maintaining a sense of optimism-Carl Rogers.Cancer Res Stat Treat 2020;3:325-326
|How to cite this URL:|
Mohan T, Nambiar K. Maintaining a sense of optimism-Carl Rogers. Cancer Res Stat Treat [serial online] 2020 [cited 2021 Dec 4 ];3:325-326
Available from: https://www.crstonline.com/text.asp?2020/3/2/325/287237
Today, we are all witnessing surreal images of our society that has come to a standstill, with deserted roads, quiet cities, and closed restaurants and bars, as the world is struggling with the coronavirus disease 2019 (COVID-19) pandemic. In such a difficult scenario, when our aim is to protect ourselves and our loved ones, the health-care professionals hail as heroes for saving our society from this dreaded virus. The recent supplement issue of Cancer Research, Statistics, and Treatment has published articles on the management strategies for patients with cancer amid the pandemic (especially in the Tata Memorial Hospital, Mumbai, India). The articles have enlightened us and answered most of our questions regarding the care of patients with cancer who are also infected with the severe acute respiratory syndrome coronavirus 2.
In the article titled, “The pattern of care in head-and-neck cancer: Comparison between before and during the COVID-19 pandemic,” the authors have congruously explained how the treatment was planned and administered to the patients during the pre-COVID, start-COVID, and established-COVID time periods. We have not come across any such reported articles since the COVID-19 outbreak. The dosage recommendations and the data reported appear noteworthy and can open doors for further research. Just when I thought it could not get any better, came another very informative review article titled, “COVID-19 and head and neck cancer treatment.” This review further elucidated the available treatment options and precisely elaborated on the treatment strategies for cancers of the oral cavity, oropharynx, and nasopharynx with lymph node metastasis. It importantly highlights how the long waiting period during the COVID-19 pandemic can impact the outcomes and lead to disease progression and how the authors have strategically tackled this problem with neoadjuvant chemotherapy. However, we believe that there is a need for additional information regarding changes in the treatment strategy for human papillomavirus- or Epstein–Barr virus-positive patients. Moreover, what happens to the patients who have undergone cervical lymph node dissection, such as those with oral or occult tongue cancers, was not discussed. This information would have been valuable, as such patients already have their immunity compromised. Nevertheless, the rest of the information was very helpful.
Lastly, we would like to comment on an unconventional article published in this issue, “Into the past in the times of COVID pandemic.” We were stupefied by how the ancient Indian history and the texts from Sushruta Samhita/manuscripts by Sushruta contained knowledge about the epidemics. It was truly a gripping article and gave a ray of hope that we shall survive this global pandemic too.
We would like to conclude by saying that the articles in this supplement issue have the essence of petrichor on the meadows of our brains.
Financial support and sponsorship
Conflicts of interest
There are no conflicts of interest.
|1||Patil VM, Srikanth A, Noronha V, Joshi A, Dhumal S, Menon N, et al. The pattern of care in head-and-neck cancer: Comparison between before and during the COVID-19 pandemic. Cancer Res Statist Treat 2020;3 Suppl S1:7-12.|
|2||Patil V, Noronha V, Chaturvedi P, Talapatra K, Joshi A, Menon N, et al. COVID-19 and head and neck cancer treatment. Cancer Res Statist Treat 2020;3 Suppl S1:15-28.|
|3||Chaturvedi P, Ramalingam N. Into the past in the times of COVID pandemic. Cancer Re Statist Treat 2020;3 Suppl S1:94-6.|